Celldex Therapeutics Cash from Operations Quarterly:
-17.20M for March 31, 2013Celldex Therapeutics Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -17.20M |
| Dec. 31, 2012 | -13.33M |
| Sept. 30, 2012 | -10.94M |
| June 30, 2012 | -11.96M |
| March 31, 2012 | -13.55M |
| Dec. 31, 2011 | -9.37M |
| Sept. 30, 2011 | -8.059M |
| June 30, 2011 | -9.365M |
| March 31, 2011 | -8.864M |
| Dec. 31, 2010 | -6.015M |
| Sept. 30, 2010 | -7.742M |
| June 30, 2010 | -9.675M |
| March 31, 2010 | -6.94M |
| Dec. 31, 2009 | -10.84M |
| Sept. 30, 2009 | -5.504M |
| June 30, 2009 | -7.972M |
| March 31, 2009 | -5.55M |
| Dec. 31, 2008 | 1.294M |
| Sept. 30, 2008 | -8.979M |
| June 30, 2008 | 30.27M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
CLDX Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Array BioPharma | |
| Ariad Pharmaceuticals | -68.45M |
| Insmed | -8.926M |
CLDX Cash from Operations Quarterly Rankings
| Overall |
47th percentile 4223 of 8002 |
| Sector |
25th percentile 513 of 684 in Healthcare |
| Industry |
29th percentile 176 of 248 in Biotechnology |
CLDX Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -17.20M | Mar 2013 |
| Maximum | 30.27M | Jun 2008 |
| Average | -7.015M |
